B. Aronsson

2.0k total citations
40 papers, 1.5k citations indexed

About

B. Aronsson is a scholar working on Infectious Diseases, Epidemiology and Gastroenterology. According to data from OpenAlex, B. Aronsson has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 17 papers in Epidemiology and 7 papers in Gastroenterology. Recurrent topics in B. Aronsson's work include Clostridium difficile and Clostridium perfringens research (17 papers), Microscopic Colitis (10 papers) and Gastrointestinal motility and disorders (7 papers). B. Aronsson is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (17 papers), Microscopic Colitis (10 papers) and Gastrointestinal motility and disorders (7 papers). B. Aronsson collaborates with scholars based in Sweden, Netherlands and United Kingdom. B. Aronsson's co-authors include R. Möllby, C. E. Nord, Nord Ce, S Sjölin, Anna Schwan, Inge C. Gyssens, Otto Cars, Anthony D. So, Dominique L. Monnet and Marta Granström and has published in prestigious journals such as Nature Reviews Drug Discovery, The Journal of Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

B. Aronsson

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Aronsson Sweden 21 838 636 244 132 126 40 1.5k
Lynda Fenelon Ireland 21 725 0.9× 736 1.2× 136 0.6× 225 1.7× 54 0.4× 53 2.3k
Shira Doron United States 20 605 0.7× 466 0.7× 643 2.6× 112 0.8× 26 0.2× 81 2.2k
Richard Slack United Kingdom 22 368 0.4× 609 1.0× 137 0.6× 51 0.4× 28 0.2× 77 1.8k
Ioannis M. Zacharioudakis United States 23 1.3k 1.6× 927 1.5× 265 1.1× 235 1.8× 26 0.2× 60 1.9k
Larry J. Strausbaugh United States 25 1.1k 1.3× 896 1.4× 139 0.6× 327 2.5× 33 0.3× 61 2.2k
Alice Guh United States 22 1.3k 1.5× 1000 1.6× 282 1.2× 320 2.4× 21 0.2× 66 2.2k
Robin Howe United Kingdom 27 966 1.2× 606 1.0× 645 2.6× 59 0.4× 35 0.3× 56 2.3k
Erika Vlieghe Belgium 25 457 0.5× 431 0.7× 155 0.6× 74 0.6× 57 0.5× 84 1.9k
Steven P Gelone United States 17 761 0.9× 663 1.0× 87 0.4× 93 0.7× 11 0.1× 52 1.2k
Bjørn Blomberg Norway 30 767 0.9× 873 1.4× 209 0.9× 36 0.3× 86 0.7× 114 2.8k

Countries citing papers authored by B. Aronsson

Since Specialization
Citations

This map shows the geographic impact of B. Aronsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Aronsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Aronsson more than expected).

Fields of papers citing papers by B. Aronsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Aronsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Aronsson. The network helps show where B. Aronsson may publish in the future.

Co-authorship network of co-authors of B. Aronsson

This figure shows the co-authorship network connecting the top 25 collaborators of B. Aronsson. A scholar is included among the top collaborators of B. Aronsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Aronsson. B. Aronsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aronsson, B., et al.. (2011). Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now. Drug Resistance Updates. 14(2). 118–124. 259 indexed citations
2.
Eichler, Hans‐Georg, B. Aronsson, Éric Abadie, & Tomas Salmonson. (2010). New drug approval success rate in Europe in 2009. Nature Reviews Drug Discovery. 9(5). 355–356. 26 indexed citations
3.
Aronsson, B., Charlotte Wiberg, Per Sandstedt, & Anders Hjern. (2009). Asylum‐seeking children with severe loss of activities of daily living: clinical signs and course during rehabilitation. Acta Paediatrica. 98(12). 1977–1981. 20 indexed citations
4.
Vorsters, Alex, Greet Hendrickx, Paolo Bonanni, et al.. (2009). A summer school on vaccinology: Responding to identified gaps in pre-service immunisation training of future health care workers. Vaccine. 28(9). 2053–2059. 43 indexed citations
5.
Regnström, Jan, Franz Koenig, B. Aronsson, et al.. (2009). Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency. European Journal of Clinical Pharmacology. 66(1). 39–48. 83 indexed citations
6.
Pignatti, Francesco, et al.. (2002). Clinical trials for registration in the European Union: the EMEA 5-year experience in oncology. Critical Reviews in Oncology/Hematology. 42(2). 123–135. 8 indexed citations
7.
Pignatti, Francesco, et al.. (2002). The review of drug applications submitted to the European Medicines Evaluation Agency: frequently raised objections, and outcome. European Journal of Clinical Pharmacology. 58(9). 573–580. 28 indexed citations
8.
9.
Aronsson, B., et al.. (1994). Prevalence of Antibodies against Hepatitis C Virus Infection among Health Care Workers in Stockholm. Scandinavian Journal of Gastroenterology. 29(4). 360–362. 34 indexed citations
10.
Wilton, Jane, et al.. (1992). Comparative evaluation of a new molecular method for typingStaphylococcus epidermidis. European Journal of Clinical Microbiology & Infectious Diseases. 11(6). 515–521. 12 indexed citations
11.
Aronsson, B., et al.. (1992). Intramuscular versus Intradermal Administration of a Recombinant Hepatitis B Vaccine: A Comparison of Response Rates and Analysis of Factors Influencing the Antibody Response. Scandinavian Journal of Infectious Diseases. 24(4). 423–429. 47 indexed citations
12.
Aronsson, B., et al.. (1992). Low levels of coagulation inhibitors in patients withClostridium difficile infection. Infection. 20(2). 58–60. 5 indexed citations
13.
Aronsson, B., et al.. (1991). Gentamicin-resistant klebsiella spp. and escherichia coli in a neonatal intensive care unit. Scandinavian Journal of Infectious Diseases. 23(2). 195–199. 8 indexed citations
14.
Aronsson, B., et al.. (1990). Rapid diagnosis of Clostridium difficile ‐associated diarrhoea using a latex agglutination test. Apmis. 98(7-12). 652–654. 2 indexed citations
15.
Aronsson, B., et al.. (1989). Medical Implications of Nosocomial Infection with Clostridium difficile. Scandinavian Journal of Infectious Diseases. 21(6). 733–734. 28 indexed citations
16.
Tullus, Kjell, B. Aronsson, Samuel N. Marcus, & R. Möllby. (1989). Intestinal colonization withClostridium difficile in infants up to 18 months of age. European Journal of Clinical Microbiology & Infectious Diseases. 8(5). 390–393. 85 indexed citations
17.
Aronsson, B., Marta Granström, R. Möllby, & Nord Ce. (1985). Enzyme immunoassay for detection ofClostridium difficile toxins a and b in patients with antibiotic-associated diarrhoea and colitis. European Journal of Clinical Microbiology & Infectious Diseases. 4(2). 102–107. 18 indexed citations
18.
Aronsson, B., R. Möllby, & Nord Ce. (1984). Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden. Journal of Antimicrobial Chemotherapy. 14(suppl D). 85–95. 37 indexed citations
19.
Aronsson, B., et al.. (1981). Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Annals of Tropical Medicine and Parasitology. 75(4). 367–373. 29 indexed citations
20.
Aronsson, B., R. Möllby, & C. E. Nord. (1981). Occurrence of toxin-producingClostridium difficile in antibiotic-associated diarrhea in Sweden. Medical Microbiology and Immunology. 170(1). 27–35. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynda Fenelon Breakdown of academic impact, for papers by Shira Doron Breakdown of academic impact, for papers by Richard Slack Breakdown of academic impact, for papers by Ioannis M. Zacharioudakis Breakdown of academic impact, for papers by Larry J. Strausbaugh Breakdown of academic impact, for papers by Alice Guh Breakdown of academic impact, for papers by Robin Howe Breakdown of academic impact, for papers by Erika Vlieghe Breakdown of academic impact, for papers by Steven P Gelone Breakdown of academic impact, for papers by Bjørn Blomberg
Rankless by CCL
2026